Management of digoxin therapy using pharmacokinetics in a patient undergoing continuous venovenous hemofiltration

Scott T. Benken*, Bryan D. Lizza, Hala Yamout, Cybele Ghossein

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Purpose. The management of digoxin therapy using pharmacokinetics in a patient undergoing continuous venovenous hemofiltration (CVVH) is reported. Summary. A 46-year-old African-American woman with New York Heart Association class IV, American College of Cardiology-American Heart Association stage D heart failure arrived from an outside facility with complaints of dyspnea after minimal exertion, orthopnea, and lower-extremity edema. A transthoracic echocardiogram revealed an estimated left ventricular ejection fraction of 15%. The patient subsequently required left ventricular assist device placement on hospital day 5 as a potential bridge to transplantation. A total digoxin loading dose of 500 μg i.v. (8.2 μg/kg) was given in two divided doses six hours apart. The next morning, the serum digoxin concentration was 1.9 ng/mL, and the patient was started on a maintenance digoxin dosage of 125 μg i.v. daily. On postoperative day (POD) 20, the patient developed acute kidney injury, and CVVH was initiated. The sieving coefficient (Sc), transmembrane clearance (CLtm), digoxin concentration in ultrafiltration fluid (Cuf), and need for supplemental digoxin were determined to account for CVVH-associated digoxin loss. After 14 days of CVVH, the patient's clinical condition improved, and CVVH was transitioned to intermittent hemodialysis. On POD 66, the patient was discharged to an extended-care facility without adverse reactions related to digoxin therapy. Conclusion. Analysis of serum digoxin concentration and digoxin Cuf values suggested that digoxin was cleared by CVVH, allowed calculation of Sc and CLtm values, and facilitated determination of digoxin requirements in a critically ill patient requiring CVVH.

Original languageEnglish (US)
Pages (from-to)2105-2109
Number of pages5
JournalAmerican Journal of Health-System Pharmacy
Volume70
Issue number23
DOIs
StatePublished - Dec 1 2013

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy

Fingerprint Dive into the research topics of 'Management of digoxin therapy using pharmacokinetics in a patient undergoing continuous venovenous hemofiltration'. Together they form a unique fingerprint.

Cite this